Actively Recruiting
Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
Led by University of Vienna · Updated on 2026-02-18
30
Participants Needed
1
Research Sites
77 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.
CONDITIONS
Official Title
Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
- Indication for mediastinal staging
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Vienna
Vienna, Austria
Actively Recruiting
Research Team
D
Daniela Gompelmann
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here